IQVIA Holdings Inc. IQV
i
Market dataready · fetched 2026-11-12T14:59:56.568Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T14:59:46.573103549Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T14:59:56.123756+00:00
IQVIA Holdings Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 288.16 | 44.2% | 6.8% | 255.83 | 48.5% | 6.6% |
| 25Δ | 284.77 | 42.7% | 5.8% | 260.16 | 45.9% | 5.2% |
| 30Δ | 281.39 | 41.3% | 4.8% | 262.65 | 45.5% | 4.6% |
| 35Δ | 278.74 | 40.8% | 4.1% | 265.13 | 45.1% | 4.0% |
| 40Δ | 276.60 | 41.0% | 3.6% | 267.62 | 44.7% | 3.4% |
| 45Δ | 274.46 | 41.2% | 3.2% | 270.10 | 44.4% | 2.8% |
| 50Δ | 272.32 | 41.3% | 2.7% | 272.33 | 43.9% | 2.5% |
| 55Δ | 270.18 | 41.5% | 2.3% | 274.57 | 43.5% | 2.1% |
| 60Δ | 267.77 | 42.2% | 2.0% | 276.80 | 43.1% | 1.7% |
| 65Δ | 265.34 | 42.9% | 1.7% | 279.04 | 42.7% | 1.4% |
| 70Δ | 262.91 | 43.5% | 1.4% | 281.61 | 42.3% | 1.1% |
| 75Δ | 260.48 | 44.2% | 1.1% | 284.43 | 42.0% | 0.8% |
| 80Δ | 256.66 | 46.1% | 0.9% | 287.24 | 41.6% | 0.6% |
20Δ
- Pseudo strike
- 288.16
- IV
- 44.2%
- B/E move
- 6.8%
- Pseudo strike
- 255.83
- IV
- 48.5%
- B/E move
- 6.6%
25Δ
- Pseudo strike
- 284.77
- IV
- 42.7%
- B/E move
- 5.8%
- Pseudo strike
- 260.16
- IV
- 45.9%
- B/E move
- 5.2%
30Δ
- Pseudo strike
- 281.39
- IV
- 41.3%
- B/E move
- 4.8%
- Pseudo strike
- 262.65
- IV
- 45.5%
- B/E move
- 4.6%
35Δ
- Pseudo strike
- 278.74
- IV
- 40.8%
- B/E move
- 4.1%
- Pseudo strike
- 265.13
- IV
- 45.1%
- B/E move
- 4.0%
40Δ
- Pseudo strike
- 276.60
- IV
- 41.0%
- B/E move
- 3.6%
- Pseudo strike
- 267.62
- IV
- 44.7%
- B/E move
- 3.4%
45Δ
- Pseudo strike
- 274.46
- IV
- 41.2%
- B/E move
- 3.2%
- Pseudo strike
- 270.10
- IV
- 44.4%
- B/E move
- 2.8%
50Δ
- Pseudo strike
- 272.32
- IV
- 41.3%
- B/E move
- 2.7%
- Pseudo strike
- 272.33
- IV
- 43.9%
- B/E move
- 2.5%
55Δ
- Pseudo strike
- 270.18
- IV
- 41.5%
- B/E move
- 2.3%
- Pseudo strike
- 274.57
- IV
- 43.5%
- B/E move
- 2.1%
60Δ
- Pseudo strike
- 267.77
- IV
- 42.2%
- B/E move
- 2.0%
- Pseudo strike
- 276.80
- IV
- 43.1%
- B/E move
- 1.7%
65Δ
- Pseudo strike
- 265.34
- IV
- 42.9%
- B/E move
- 1.7%
- Pseudo strike
- 279.04
- IV
- 42.7%
- B/E move
- 1.4%
70Δ
- Pseudo strike
- 262.91
- IV
- 43.5%
- B/E move
- 1.4%
- Pseudo strike
- 281.61
- IV
- 42.3%
- B/E move
- 1.1%
75Δ
- Pseudo strike
- 260.48
- IV
- 44.2%
- B/E move
- 1.1%
- Pseudo strike
- 284.43
- IV
- 42.0%
- B/E move
- 0.8%
80Δ
- Pseudo strike
- 256.66
- IV
- 46.1%
- B/E move
- 0.9%
- Pseudo strike
- 287.24
- IV
- 41.6%
- B/E move
- 0.6%
Options history
Table
| Date | IV (%) |
|---|---|
| 34.82% | |
| 36.22% | |
| 36.77% | |
| 36.15% | |
| 36.65% | |
| 36.23% | |
| 36.34% | |
| 35.74% | |
| 34.78% | |
| 34.52% | |
| 35.58% | |
| 35.24% | |
| 34.80% | |
| 35.90% | |
| 37.28% | |
| 38.00% | |
| 37.19% | |
| 37.20% | |
| 39.17% | |
| 39.54% | |
| 38.85% | |
| 38.19% | |
| 36.61% | |
| 37.56% | |
| 37.55% | |
| 38.40% | |
| 38.14% | |
| 37.68% | |
| 37.59% | |
| 38.04% | |
| 38.04% | |
| 37.53% | |
| 37.61% | |
| 37.64% | |
| 39.10% | |
| 39.16% | |
| 39.42% | |
| 39.24% | |
| 39.78% | |
| 40.76% | |
| 40.83% | |
| 42.11% | |
| 41.52% | |
| 41.79% | |
| 42.47% | |
| 42.82% | |
| 43.23% | |
| 42.66% | |
| 43.40% | |
| 35.93% | |
| 36.46% | |
| 35.66% | |
| 38.42% |
Diagnostics & Research
LH
Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest…
More →MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in…
More →MTD
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory,…
More →MYGN
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The…
More →NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
More →NTRA
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
More →